Predicting and preventing hospital readmission for exacerbations of COPD

Chia Wei Kong, Tom M A Wilkinson, Chia Wei Kong, Tom M A Wilkinson

Abstract

More than a third of patients hospitalised for acute exacerbation of COPD are readmitted to hospital within 90 days. Healthcare professionals and service providers are expected to collaboratively drive efforts to improve hospital readmission rates, which can be challenging due to the lack of clear consensus and guidelines on how best to predict and prevent readmissions. This review identifies these risk factors, highlighting the contribution of multimorbidity, frailty and poor socioeconomic status. Predictive models of readmission that address the multifactorial nature of readmissions and heterogeneity of the disease are reviewed, recognising that in an era of precision medicine, in-depth understanding of the intricate biological mechanisms that heighten the risk of COPD exacerbation and re-exacerbation is needed to derive modifiable biomarkers that can stratify accurately the highest risk groups for targeted treatment. We evaluate conventional and emerging strategies to reduce these potentially preventable readmissions. Here, early recognition of exacerbation symptoms and the delivery of prompt treatment can reduce risk of hospital admissions, while patient education can improve treatment adherence as a key component of self-management strategies. Care bundles are recommended to ensure high-quality care is provided consistently, but evidence for their benefit is limited to date. The search continues for interventions which are effective, sustainable and applicable to a diverse population of patients with COPD exacerbations. Further research into mechanisms that drive exacerbation and affect recovery is crucial to improve our understanding of this complex, highly prevalent disease and to advance the development of more effective treatments.

Conflict of interest statement

Conflict of interest: C.W. Kong has nothing to disclose. Conflict of interest: T.M.A. Wilkinson reports grants and personal fees from GSK and AZ; grants and personal fees from MMH, of which he is a company director; personal fees and nonfinancial support from BI; grants and personal fees from Synairgen, during the conduct of the study; and personal fees from MMH outside the submitted work.

Copyright ©ERS 2020.

References

    1. Wedzicha JA, Wilkinson T. Impact of chronic obstructive pulmonary disease exacerbations on patients and payers. Proc Am Thorac Soc 2006; 3: 218–221. doi:10.1513/pats.200510-114SF
    1. Shah T, Press VG, Huisingh-Scheetz M, et al. . COPD readmissions: addressing COPD in the era of value-based health care. Chest 2016; 150: 916–926. doi:10.1016/j.chest.2016.05.002
    1. Andersson F, Borg S, Jansson SA, et al. . The costs of exacerbations in chronic obstructive pulmonary disease (COPD). Respir Med 2002; 96: 700–708. doi:10.1053/rmed.2002.1334
    1. Jencks SF, Williams MV, Coleman EA. Rehospitalizations among patients in the Medicare fee-for-service program. N Engl J Med 2009; 360: 1418–1428. doi:10.1056/NEJMsa0803563
    1. Stone RA, Holzhauer-Barrie J, Lowe D, et al. . COPD: Who Cares When it Matters Most? National Chronic Obstructive Pulmonary Disease (COPD) Audit Programme: Outcomes from the Clinical Audit of COPD Exacerbations Admitted to Acute Units in England 2014. National Supplementary Report London, Royal College of Physicians, 2017.
    1. Hartl S, Lopez-Campos JL, Pozo-Rodriguez F, et al. . Risk of death and readmission of hospital-admitted COPD exacerbations: European COPD audit. Eur Respir J 2016; 47: 113–121. doi:10.1183/13993003.01391-2014
    1. Connolly MJ, Lowe D, Anstey K, et al. . Admissions to hospital with exacerbations of chronic obstructive pulmonary disease: effect of age related factors and service organisation. Thorax 2006; 61: 843–848. doi:10.1136/thx.2005.054924
    1. Baker CL, Zou KH, Su J. Risk assessment of readmissions following an initial COPD-related hospitalization. Int J Chron Obstruct Pulmon Dis 2013; 8: 551–559.
    1. Tsui MS, Lun FCT, Cheng LSL, et al. . Risk factors for hospital readmission for COPD after implementation of the GOLD guidelines. Int J Tuberc Lung Dis 2016; 20: 396–401. doi:10.5588/ijtld.15.0256
    1. Soler-Cataluña JJ, Martínez-García MÁ, Román Sánchez P, et al. . Severe acute exacerbations and mortality in patients with chronic obstructive pulmonary disease. Thorax 2005; 60: 925–931. doi:10.1136/thx.2005.040527
    1. Shah T, Churpek MM, Coca Perraillon M. Understanding why patients with COPD get readmitted: a large national study to delineate the Medicare population for the readmissions penalty expansion. Chest 2015; 147: 1219–1226. doi:10.1378/chest.14-2181
    1. Anecchino C, Rossi E, Fanizza C, et al. . Prevalence of chronic obstructive pulmonary disease and pattern of comorbidities in a general population. Int J Chron Obstruct Pulmon Dis 2007; 2: 567–574.
    1. Yin HL, Yin SQ, Lin QY, et al. . Prevalence of comorbidities in chronic obstructive pulmonary disease patients: a meta-analysis. Medicine 2017; 96: e6836.
    1. Fumagalli G, Fabiani F, Forte S, et al. . INDACO project: COPD and link between comorbidities, lung function and inhalation therapy. Multidiscip Respir Med 2015; 10: 4. doi:10.4081/mrm.2015.277
    1. Jiang X, Xiao H, Segal R, et al. . Trends in readmission rates, hospital charges, and mortality for patients with chronic obstructive pulmonary disease (COPD) in Florida from 2009 to 2014. Clin Ther 2018; 40: 613–626. doi:10.1016/j.clinthera.2018.03.006
    1. Sharif R, Parekh T, Kuo Y-F, et al. . Predictors of early readmission among patients hospitalized with chronic obstructive pulmonary disease. Chest 2014; 145: 420A. doi:10.1378/chest.1722770
    1. Wong AWM, Gan WQ, Burns J, et al. . Acute exacerbation of chronic obstructive pulmonary disease: influence of social factors in determining length of hospital stay and readmission rates. Can Respir J 2008; 15: 361–364. doi:10.1155/2008/569496
    1. Iyer AS, Bhatt SP, Garner JJ, et al. . Depression is associated with readmission for acute exacerbation of chronic obstructive pulmonary disease. Ann Am Thorac Soc 2016; 13: 197–203. doi:10.1513/AnnalsATS.201509-618AS
    1. Light RW, Merrill EJ, Despars JA, et al. . Prevalence of depression and anxiety in patients with COPD. Relationship to functional capacity. Chest 1985; 87: 35–38. doi:10.1378/chest.87.1.35
    1. Pollock J, van Agteren J, Carson-Chahhoud K. Pharmacological interventions for the treatment of anxiety disorders in chronic obstructive pulmonary disease. Cochrane Database Syst Rev 2018; 12: CD012346.
    1. Garcia-Aymerich J, Farrero E, Félez M, et al. . Risk factors of readmission to hospital for a COPD exacerbation: a prospective study. Thorax 2003; 58: 100–105. doi:10.1136/thorax.58.2.100
    1. Nguyen HQ, Rondinelli J, Harrington A, et al. . Functional status at discharge and 30-day readmission risk in COPD. Respir Med 2015; 109: 238–246. doi:10.1016/j.rmed.2014.12.004
    1. Pitta F, Troosters T, Probst VS, et al. . Physical activity and hospitalization for exacerbation of COPD. Chest 2006; 129: 536–544. doi:10.1378/chest.129.3.536
    1. Marengoni A, Vetrano DL, Manes-Gravina E, et al. . The relationship between COPD and frailty: a systematic review and meta-analysis of observational studies. Chest 2018; 154: 21–40. doi:10.1016/j.chest.2018.02.014
    1. Fried LP, Tangen CM, Walston J, et al. . Frailty in older adults: evidence for a phenotype. J Gerontol A Biol Sci Med Sci 2001; 56: M146–M156. doi:10.1093/gerona/56.3.M146
    1. Kon SSC, Jones SE, Schofield SJ, et al. . Gait speed and readmission following hospitalisation for acute exacerbations of COPD: a prospective study. Thorax 2015; 70: 1131–1137. doi:10.1136/thoraxjnl-2015-207046
    1. Bernabeu-Mora R, García-Guillamón G, Valera-Novella E, et al. . Frailty is a predictive factor of readmission within 90 days of hospitalization for acute exacerbations of chronic obstructive pulmonary disease: a longitudinal study. Ther Adv Respir Dis 2017; 11: 383–392. doi:10.1177/1753465817726314
    1. Greening NJ, Harvey-Dunstan TC, Chaplin EJ, et al. . Bedside assessment of quadriceps muscle by ultrasound after admission for acute exacerbations of chronic respiratory disease. Am J Respir Crit Care Med 2015; 192: 810–816. doi:10.1164/rccm.201503-0535OC
    1. Global Initiative for Chronic Obstructive Lung Disease (GOLD). Global Strategy for the Diagnosis, Management and Prevention of COPD 2019. Available from:
    1. Tsoumakidou M, Tzanakis N, Voulgaraki O, et al. . Is there any correlation between the ATS, BTS, ERS and GOLD COPD's severity scales and the frequency of hospital admissions? Respir Med 2004; 98: 178–183. doi:10.1016/j.rmed.2003.09.011
    1. Gudmundsson G, Gislason T, Janson C, et al. . Risk factors for rehospitalisation in COPD: role of health status, anxiety and depression. Eur Respir J 2005; 26: 414–419. doi:10.1183/09031936.05.00078504
    1. Cao Z, Ong K, Eng P, et al. . Frequent hospital readmissions for acute exacerbation of COPD and their associated factors. Respirology 2006; 11: 188–195. doi:10.1111/j.1440-1843.2006.00819.x
    1. Wang Q, Bourbeau J. Outcomes and health-related quality of life following hospitalization for an acute exacerbation of COPD. Respirology 2005; 10: 334–340. doi:10.1111/j.1440-1843.2005.00718.x
    1. de Miguel-Díez J, Jiménez-García R, Hernández-Barrera V, et al. . Readmissions following an initial hospitalization by COPD exacerbation in Spain from 2006 to 2012. Respirology 2016; 21: 489–496.
    1. Pouw EM, Ten Velde GP, Croonen BH, et al. . Early non-elective readmission for chronic obstructive pulmonary disease is associated with weight loss. Clin Nutr 2000; 19: 95–99. doi:10.1054/clnu.1999.0074
    1. Hunter LC, Lee RJ, Butcher I, et al. . Patient characteristics associated with risk of first hospital admission and readmission for acute exacerbation of chronic obstructive pulmonary disease (COPD) following primary care COPD diagnosis: a cohort study using linked electronic patient records. BMJ Open 2016; 6: e009121. doi:10.1136/bmjopen-2015-009121
    1. Vermeeren MA, Schols AM, Wouters EF. Effects of an acute exacerbation on nutritional and metabolic profile of patients with COPD. Eur Respir J 1997; 10: 2264–2269. doi:10.1183/09031936.97.10102264
    1. Gershon AS, Dolmage TE, Stephenson A, et al. . Chronic obstructive pulmonary disease and socioeconomic status: a systematic review. COPD 2012; 9: 216–226. doi:10.3109/15412555.2011.648030
    1. Keating A, Lee A, Holland AE. What prevents people with chronic obstructive pulmonary disease from attending pulmonary rehabilitation? A systematic review. Chron Respir Dis 2011; 8: 89–99. doi:10.1177/1479972310393756
    1. Steer J, Gibson J, Bourke SC. The DECAF score: predicting hospital mortality in exacerbations of chronic obstructive pulmonary disease. Thorax 2012; 67: 970–976. doi:10.1136/thoraxjnl-2012-202103
    1. Chu CM, Chan VL, Lin AWN, et al. . Readmission rates and life threatening events in COPD survivors treated with non-invasive ventilation for acute hypercapnic respiratory failure. Thorax 2004; 59: 1020–1025. doi:10.1136/thx.2004.024307
    1. Confalonieri M, Garuti G, Cattaruzza MS, et al. . A chart of failure risk for noninvasive ventilation in patients with COPD exacerbation. Eur Respir J 2005; 25: 348–355. doi:10.1183/09031936.05.00085304
    1. Lun CT, Chan VL, Leung WS, et al. . A pilot randomized study comparing two methods of non-invasive ventilation withdrawal after acute respiratory failure in chronic obstructive pulmonary disease. Respirology 2013; 18: 814–819. doi:10.1111/resp.12080
    1. Sellares J, Ferrer M, Anton A, et al. . Discontinuing noninvasive ventilation in severe chronic obstructive pulmonary disease exacerbations: a randomised controlled trial. Eur Respir J 2017; 50: 1601448. doi:10.1183/13993003.01448-2016
    1. Wilkinson TMA, Donaldson GC, Hurst JR, et al. . Early therapy improves outcomes of exacerbations of chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2004; 169: 1298–1303. doi:10.1164/rccm.200310-1443OC
    1. Donaldson GC, Seemungal TAR, Bhowmik A, et al. . Relationship between exacerbation frequency and lung function decline in chronic obstructive pulmonary disease. Thorax 2002; 57: 847–852.
    1. Hurst J, Vestbo J, Anzueto A, et al. . Susceptibility to exacerbation in chronic obstructive pulmonary disease. N Engl J Med 2010; 363: 1128–1138. doi:10.1056/NEJMoa0909883
    1. Perera WR, Hurst JR, Wilkinson TMA, et al. . Inflammatory changes, recovery and recurrence at COPD exacerbation. Eur Respir J 2007; 29: 527–534. doi:10.1183/09031936.00092506
    1. Duman D, Aksoy E, Agca MC, et al. . The utility of inflammatory markers to predict readmissions and mortality in COPD cases with or without eosinophilia. Int J Chron Obstruct Pulmon Dis 2015; 10: 2469–2478. doi:10.2147/COPD.S90330
    1. Vermeersch K, Belmans A, Bogaerts K, et al. . Treatment failure and hospital readmissions in severe COPD exacerbations treated with azithromycin versus placebo – a post-hoc analysis of the BACE randomized controlled trial. Respir Res 2019; 20: 237. doi:10.1186/s12931-019-1208-6
    1. Hurst JR, Donaldson GC, Wilkinson TMA, et al. . Epidemiological relationships between the common cold and exacerbation frequency in COPD. Eur Respir J 2005; 26: 846–852. doi:10.1183/09031936.05.00043405
    1. Hewitt R, Farne H, Ritchie A, et al. . The role of viral infections in exacerbations of chronic obstructive pulmonary disease and asthma. Ther Adv Respir Dis 2016; 10: 158–174. doi:10.1177/1753465815618113
    1. Wark PAB, Tooze M, Powell H, et al. . Viral and bacterial infection in acute asthma and chronic obstructive pulmonary disease increases the risk of readmission. Respirology 2013; 18: 996–1002. doi:10.1111/resp.12099
    1. Bekkat-Berkani R, Wilkinson T, Buchy P, et al. . Seasonal influenza vaccination in patients with COPD: a systematic literature review. BMC Pulm Med 2017; 17: 79. doi:10.1186/s12890-017-0420-8
    1. Watson A, Spalluto CM, McCrae C, et al. . Dynamics of IFN-β responses during respiratory viral infection. Insights for therapeutic strategies. Am J Respir Crit Care Med 2020; 201: 83–94. doi:10.1164/rccm.201901-0214OC
    1. Cabello H, Torres A, Celis R, et al. . Bacterial colonization of distal airways in healthy subjects and chronic lung disease: a bronchoscopic study. Eur Respir J 1997; 10: 1137–1144. doi:10.1183/09031936.97.10051137
    1. Patel IS, Seemungal TAR, Wilks M, et al. . Relationship between bacterial colonisation and the frequency, character, and severity of COPD exacerbations. Thorax 2002; 57: 759–764. doi:10.1136/thorax.57.9.759
    1. Mayhew D, Devos N, Lambert C, et al. . Longitudinal profiling of the lung microbiome in the AERIS study demonstrates repeatability of bacterial and eosinophilic COPD exacerbations. Thorax 2018; 73: 422–430. doi:10.1136/thoraxjnl-2017-210408
    1. Umetsu D, Ambrosino D, Quinti I, et al. . Recurrent sinopulmonary infection and impaired antibody response to bacterial capsular polysaccharide antigen in children with selective IgG-subclass deficiency. N Engl J Med 1985; 313: 1247–1251. doi:10.1056/NEJM198511143132002
    1. Popa V, Kim K, Heiner D. IgG deficiency in adults with recurrent respiratory infections. Ann Allergy 1993; 70: 418–424.
    1. Leitao Filho FS, Ra SW, Mattman A, et al. . Serum IgG subclass levels and risk of exacerbations and hospitalizations in patients with COPD. Respir Res 2018; 19: 30. doi:10.1186/s12931-018-0733-z
    1. Leitao Filho FSS, Mattman A, Schellenberg R, et al. . Hypogammaglobulinemia as a predictor of hospitalizations in COPD: a meta-analysis. Am J Respir Crit Care Med 2019; 199: A3999.
    1. Rutgers SR, Timens W, Kaufmann HF, et al. . Comparison of induced sputum with bronchial wash, bronchoalveolar lavage and bronchial biopsies in COPD. Eur Respir J 2000; 15: 109–115.
    1. Couillard S, Larivée P, Courteau J, et al. . Eosinophils in COPD exacerbations are associated with increased readmissions. Chest 2017; 151: 366–373. doi:10.1016/j.chest.2016.10.003
    1. Bélanger M, Couillard S, Courteau J, et al. . Eosinophil counts in first COPD hospitalizations: a comparison of health service utilization. Int J Chron Obstruct Pulmon Dis 2018; 13: 3045–3054.
    1. Barnes NC, Sharma R, Lettis S, et al. . Blood eosinophils as a marker of response to inhaled corticosteroids in COPD. Eur Respir J 2016; 47: 1374–1382. doi:10.1183/13993003.01370-2015
    1. Pascoe S, Locantore N, Dransfield M, et al. . Blood eosinophil counts, exacerbations, and response to the addition of inhaled fluticasone furoate to vilanterol in patients with chronic obstructive pulmonary disease: a secondary analysis of data from two parallel randomised controlled trials. Lancet Respir Med 2015; 3: 435–442. doi:10.1016/S2213-2600(15)00106-X
    1. Puhan MA, Garcia-Aymerich J, Frey M, et al. . Expansion of the prognostic assessment of patients with chronic obstructive pulmonary disease: the updated BODE index and the ADO index. Lancet 2009; 374: 704–711. doi:10.1016/S0140-6736(09)61301-5
    1. Soler-Cataluña JJ, Martínez-García MÁ, Sánchez LS, et al. . Severe exacerbations and BODE index: two independent risk factors for death in male COPD patients. Respir Med 2009; 103: 692–699. doi:10.1016/j.rmed.2008.12.005
    1. Jones RC, Donaldson GC, Chavannes NH, et al. . Derivation and validation of a composite index of severity in chronic obstructive pulmonary disease: the DOSE index. Am J Respir Crit Care Med 2009; 180: 1189–1195. doi:10.1164/rccm.200902-0271OC
    1. van Walraven C, Dhalla IA, Bell C, et al. . Derivation and validation of an index to predict early death or unplanned readmission after discharge from hospital to the community. CMAJ 2010; 182: 551–557. doi:10.1503/cmaj.091117
    1. Echevarria C, Steer J, Heslop-Marshall K, et al. . The PEARL score predicts 90-day readmission or death after hospitalisation for acute exacerbation of COPD. Thorax 2017; 72: 686–693.
    1. Hakim MA, Garden FL, Jennings MD, et al. . Performance of the LACE index to predict 30-day hospital readmissions in patients with chronic obstructive pulmonary disease. Clin Epidemiol 2018; 10: 51–59.
    1. Ostridge K, Wilkinson TMA. Present and future utility of computed tomography scanning in the assessment and management of COPD. Eur Respir J 2016; 48: 216–228. doi:10.1183/13993003.00041-2016
    1. Rothberg MB, Pekow PS, Lahti M, et al. . Antibiotic therapy and treatment failure in patients hospitalized for acute exacerbations of chronic obstructive pulmonary disease. JAMA 2019; 303: 2035–2042. doi:10.1001/jama.2010.672
    1. Stefan MS, Rothberg MB, Shieh MS, et al. . Association between antibiotic treatment and outcomes in patients hospitalized with acute exacerbation of COPD treated with systemic steroids. Chest 2013; 143: 82–90. doi:10.1378/chest.12-0649
    1. Vermeersch K, Gabrovska M, Aumann J, et al. . Azithromycin During Acute Chronic Obstructive Pulmonary Disease Exacerbations Requiring Hospitalization (BACE): a multicenter, randomized, double-blind, placebo-controlled trial. Am J Respir Crit Care Med 2019; 200: 857–868. doi:10.1164/rccm.201901-0094OC
    1. Menzel M, Akbarshahi H, Bjermer L, et al. . Azithromycin induces anti-viral effects in cultured bronchial epithelial cells from COPD patients. Sci Rep 2016; 6: 28698. doi:10.1038/srep28698
    1. Bafadhel M, McKenna S, Terry S, et al. . Acute exacerbations of chronic obstructive pulmonary disease: identification of biologic clusters and their biomarkers. Am J Respir Crit Care Med 2011; 184: 662–671. doi:10.1164/rccm.201104-0597OC
    1. Walters J, Tan D, White C, et al. . Systemic corticosteroids for acute exacerbations of chronic obstructive pulmonary disease. Cochrane Database Syst Rev 2014; 9: CD001288.
    1. Walters JA, Wang W, Morley C, et al. . Different durations of corticosteroid therapy for exacerbations of chronic obstructive pulmonary disease. Cochrane Database Syst Rev 2011; 10: CD006897.
    1. Leuppi J, Schuetz P, Bingisser R, et al. . Short-term vs conventional glucocorticoid therapy in acute exacerbations of chronic obstructive pulmonary disease: the REDUCE randomized clinical trial. JAMA 2013; 309: 2223–2231. doi:10.1001/jama.2013.5023
    1. Bafadhel M, McKenna S, Terry S, et al. . Blood eosinophils to direct corticosteroid treatment of exacerbations of chronic obstructive pulmonary disease: a randomized placebo-controlled trial. Am J Respir Crit Care Med 2012; 186: 48–55. doi:10.1164/rccm.201108-1553OC
    1. Sin DD, Tu JV. Inhaled corticosteroids and the risk of mortality and readmission in elderly patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2001; 164: 580–584. doi:10.1164/ajrccm.164.4.2009033
    1. Crim C, Calverley PMA, Anderson JA, et al. . Pneumonia risk in COPD patients receiving inhaled corticosteroids alone or in combination: TORCH study results. Eur Respir J 2009; 34: 641–647. doi:10.1183/09031936.00193908
    1. Soriano JB, Kiri VA, Pride NB, et al. . Inhaled corticosteroids with/without long-acting β-agonists reduce the risk of rehospitalization and death in COPD patients. Am J Respir Med 2003; 2: 67–74. . doi:10.1007/BF03256640
    1. Tran M, Xiang P, Rascati KL, et al. . Predictors of appropriate pharmacotherapy management of COPD exacerbations and impact on 6-month readmission. J Manag Care Spec Pharm 2016; 22: 1186–1193.
    1. Vestbo J, Anderson JA, Calverley PMA, et al. . Adherence to inhaled therapy, mortality and hospital admission in COPD. Thorax 2009; 64: 939–943. doi:10.1136/thx.2009.113662
    1. Blee J, Roux RK, Gautreaux S, et al. . Dispensing inhalers to patients with chronic obstructive pulmonary disease on hospital discharge: effects on prescription filling and readmission. Am J Health Syst Pharm 2015; 72: 1204–1208. doi:10.2146/ajhp140621
    1. Toy EL, Beaulieu NU, McHale JM, et al. . Treatment of COPD: relationships between daily dosing frequency, adherence, resource use, and costs. Respir Med 2011; 105: 435–441. doi:10.1016/j.rmed.2010.09.006
    1. Rinne ST, Castaneda J, Lindenauer PK, et al. . Chronic obstructive pulmonary disease readmissions and other measures of hospital quality. Am J Respir Crit Care Med 2017; 196: 47–55. doi:10.1164/rccm.201609-1944OC
    1. Säynäjäkangas O, Kinnunen T, Tuuponen T, et al. . Length of stay and interval to readmission in emergency hospital treatment of COPD. Age Ageing 2004; 33: 567–570. doi:10.1093/ageing/afh188
    1. Nguyen HQ, Chu L, Amy Liu IL, et al. . Associations between physical activity and 30-day readmission risk in chronic obstructive pulmonary disease. Ann Am Thorac Soc 2014; 11: 695–705. doi:10.1513/AnnalsATS.201401-017OC
    1. Neder JA, Sword D, Ward SA, et al. . Home based neuromuscular electrical stimulation as a new rehabilitative strategy for severely disabled patients with chronic obstructive pulmonary disease (COPD). Thorax 2002; 57: 333–337. doi:10.1136/thorax.57.4.333
    1. Nápolis LM, Dal Corso S, Neder JA, et al. . Neuromuscular electrical stimulation improves exercise tolerance in chronic obstructive pulmonary disease patients with better preserved fat-free mass. Clinics 2011; 66: 401–406. doi:10.1590/S1807-59322011000300006
    1. Spruit MA, Singh SJ, Garvey C, et al. . An official American Thoracic Society/ European Respiratory Society statement: key concepts and advances in pulmonary rehabilitation. Am J Respir Crit Care Med 2013; 188: e13–e64. doi:10.1164/rccm.201309-1634ST
    1. Puhan M, Scharplatz M, Troosters T, et al. . Pulmonary rehabilitation following exacerbations of chronic obstructive pulmonary disease. Cochrane Database Syst Rev 2016: 12: CD005305.
    1. Greening NJ, Williams JEA, Hussain SF, et al. . An early rehabilitation intervention to enhance recovery during hospital admission for an exacerbation of chronic respiratory disease: randomised controlled trial. BMJ 2014; 349: g4315. doi:10.1136/bmj.g4315
    1. Bourne S, DeVos R, North M, et al. . Online versus face-to-face pulmonary rehabilitation for patients with chronic obstructive pulmonary disease: randomised controlled trial. BMJ Open 2017; 7: e014580.
    1. Ferreira IM, Brooks D, White J, et al. . Nutritional supplementation for stable chronic obstructive pulmonary disease. Cochrane Database Syst Rev 2012; 12: CD000998.
    1. Snider JT, Jena AB, Linthicum MT, et al. . Effect of hospital use of oral nutritional supplementation on length of stay, hospital cost, and 30-day readmissions among Medicare patients with COPD. Chest 2015; 147: 1477–1484. doi:10.1378/chest.14-1368
    1. van de Bool C, Rutten EPA, van Helvoort A, et al. . A randomized clinical trial investigating the efficacy of targeted nutrition as adjunct to exercise training in COPD. J Cachexia Sarcopenia Muscle 2017; 8: 748–758. doi:10.1002/jcsm.12219
    1. Murphy PB, Rehal S, Arbane G, et al. . Effect of home noninvasive ventilation with oxygen therapy vs oxygen therapy alone on hospital readmission or death after an acute COPD exacerbation: a randomized clinical trial. JAMA 2017; 317: 2177–2186. doi:10.1001/jama.2017.4451
    1. Lellouche F, Bouchard PA, Roberge M, et al. . Automated oxygen titration and weaning with FreeO2 in patients with acute exacerbation of COPD: a pilot randomized trial. Int J Chron Obstruct Pulmon Dis 2016; 11: 1983–1990. doi:10.2147/COPD.S112820
    1. Plant PK, Owen JL, Elliott MW. One year period prevalence study of respiratory acidosis in acute exacerbations of COPD: implications for the provision of non-invasive ventilation and oxygen administration. Thorax 2000; 55: 550–554. doi:10.1136/thorax.55.7.550
    1. Eaton T, Fergusson W, Kolbe J, et al. . Short-burst oxygen therapy for COPD patients: a 6-month randomised, controlled study. Eur Respir J 2006; 27: 697–704. doi:10.1183/09031936.06.00098805
    1. Hardinge M, Suntharalingam J, Wilkinson T. Guideline update: The British Thoracic Society Guidelines on home oxygen use in adults. Thorax 2015; 70: 589–591. doi:10.1136/thoraxjnl-2015-206918
    1. Cranston JM, Crockett A, Moss J, et al. . Domiciliary oxygen for chronic obstructive pulmonary disease. Cochrane Database Syst Rev 2005; 4: CD001744.
    1. Ringbaek TJ, Fabricius P, Lange P. The effect of home oxygen therapy on hospitalization in moderate hypoxaemic COPD. Chron Respir Dis 2005; 2: 107–108. doi:10.1191/1479972305cd055xx
    1. Ringbaek TJ, Viskum K, Lange P. Does long-term oxygen therapy reduce hospitalisation in hypoxaemic chronic obstructive pulmonary disease? Eur Respir J 2002; 20: 38–42. doi:10.1183/09031936.02.00284202
    1. Clini E, Vitacca M, Foglio K, et al. . Long-term home care programmes may reduce hospital admissions in COPD with chronic hypercapnia. Eur Respir J 1996; 9: 1605–1610. doi:10.1183/09031936.96.09081605
    1. Maddocks M, Lovell N, Booth S, et al. . Palliative care and management of troublesome symptoms for people with chronic obstructive pulmonary disease. Lancet 2017; 390: 988–1002. doi:10.1016/S0140-6736(17)32127-X
    1. Brian Cassel J, Kerr KM, McClish DK, et al. . Effect of a home-based palliative care program on healthcare use and costs. J Am Geriatr Soc 2016; 64: 2288–2295. doi:10.1111/jgs.14354
    1. Duenk RG, Verhagen C, Bronkhorst EM, et al. . Proactive palliative care for patients with COPD (PROLONG): a pragmatic cluster controlled trial. Int J Chron Obstruct Pulmon Dis 2017; 12: 2795–2806. doi:10.2147/COPD.S141974
    1. Tavares N, Jarrett N, Hunt K, et al. . Palliative and end-of-life care conversations in COPD: a systematic literature review. ERJ Open Res 2017; 3: 00068-2016.
    1. Schulman-Green D, Jaser S, Martin F, et al. . Processes of self-management in chronic illness. J Nurs Scholarsh 2012; 44: 136–144. doi:10.1111/j.1547-5069.2012.01444.x
    1. Effing T, Monninkhof EM, van der Valk PD, et al. . Self-management education for patients with chronic obstructive pulmonary disease. Cochrane Database Syst Rev 2007: CD002990.
    1. Benzo R, Vickers K, Novotny PJ, et al. . Health coaching and chronic obstructive pulmonary disease rehospitalization: a randomized study. Am J Respir Crit Care Med 2016; 194: 672–680. doi:10.1164/rccm.201512-2503OC
    1. Rice KL, Dewan N, Bloomfield HE, et al. . Disease management program for chronic obstructive pulmonary disease: a randomized controlled trial. Am J Respir Crit Care Med 2010; 182: 890–896. doi:10.1164/rccm.200910-1579OC
    1. Bourbeau J, Julien M, Maltais F, et al. . Reduction of hospital utilization in patients with chronic obstructive pulmonary disease: a disease-specific self-management intervention. Arch Intern Med 2003; 163: 585–591. doi:10.1001/archinte.163.5.585
    1. Collinsworth AW, Brown RM, James CS, et al. . The impact of patient education and shared decision making on hospital readmissions for COPD. Int J Chron Obstruct Pulmon Dis 2018; 13: 1325–1332.
    1. Aboumatar H, Naqibuddin M, Chung S, et al. . Effect of a hospital-initiated program combining transitional care and long-term self-management support on outcomes of patients hospitalized with chronic obstructive pulmonary disease: a randomized clinical trial. JAMA 2019; 322: 1371–1380. doi:10.1001/jama.2019.11982
    1. Disler RT, Gallagher RD, Davidson PM. Factors influencing self-management in chronic obstructive pulmonary disease: an integrative review. Int J Nurs Stud 2012; 49: 230–242. doi:10.1016/j.ijnurstu.2011.11.005
    1. Ospina MB, Mrklas K, Deuchar L, et al. . A systematic review of the effectiveness of discharge care bundles for patients with COPD. Thorax 2017; 72: 31–39. doi:10.1136/thoraxjnl-2016-208820
    1. Turner AM, Lim WS, Rodrigo C, et al. . A care-bundles approach to improving standard of care in AECOPD admissions: results of a national project. Thorax 2015; 70: 992–994. doi:10.1136/thoraxjnl-2015-206833
    1. Ohar JA, Loh CH, Lenoir KM, et al. . A comprehensive care plan that reduces readmissions after acute exacerbations of COPD. Respir Med 2018; 141: 20–25. doi:10.1016/j.rmed.2018.06.014
    1. Morton K, MacNeill S, Sanderson E, et al. . Evaluation of ‘care bundles’ for patients with chronic obstructive pulmonary disease (COPD): a multisite study in the UK. BMJ Open Respir Res 2019; 6: e000425.
    1. Zafar MA, Panos RJ, Ko J, et al. . Reliable adherence to a COPD care bundle mitigates system-level failures and reduces COPD readmissions: a system redesign using improvement science. BMJ Qual Saf 2017; 26: 908–918. doi:10.1136/bmjqs-2017-006529
    1. Hernandez C, Casas A, Escarrabill J, et al. . Home hospitalisation of exacerbated chronic obstructive pulmonary disease patients. Eur Respir J 2003; 21: 58–67. doi:10.1183/09031936.03.00015603
    1. Jeppesen E, Brurberg KG, Vist GE, et al. . Hospital at home for acute exacerbations of chronic obstructive pulmonary disease. Cochrane Database Syst Rev 2012; 5: CD003573.

Source: PubMed

Sponsorer og samarbejdspartnere

Medicinske tilstande

Narkotikainterventioner

3
Abonner